+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Complementary & Alternative Medicine For Anti Aging & Longevity Market by Product Type, Distribution Channel, End User, Therapy Type, Age Group, Gender - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5665938
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Complementary & Alternative Medicine For Anti Aging & Longevity Market grew from USD 51.87 billion in 2024 to USD 61.93 billion in 2025. It is expected to continue growing at a CAGR of 18.86%, reaching USD 146.29 billion by 2030.

Understanding the Surge of Anti-Aging and Longevity Modalities

Consumer enthusiasm for anti-aging and longevity solutions has reached unprecedented levels as global life expectancy rises and healthspan priorities take center stage. Advances in molecular biology, coupled with growing awareness of preventive health, are driving individuals to explore modalities that promise vitality and resilience beyond chronological years. Amid shifting demographics, with aging populations in developed markets and millennials embracing wellness earlier in life, the anti-aging sector has transcended niche status to become a cornerstone of modern healthcare and lifestyle industries.

In this dynamic environment, stakeholders across pharmaceuticals, nutraceuticals, and wellness services are converging to develop holistic strategies that address cellular senescence, metabolic health, and cognitive function. Innovations in botanical science are uncovering new extracts with epigenetic potential, while digital health platforms leverage data analytics to personalize regimens for optimal longevity benefits. Simultaneously, cross-disciplinary collaborations are inspiring integrative therapies that blend traditional medicine with cutting-edge biotech, reshaping consumer expectations and competitive landscapes.

This executive summary synthesizes the critical drivers behind this surge in anti-aging solutions, offering a window into emerging research, regulatory shifts, and evolving market structures. It aims to enable decision-makers to navigate complexities, identify growth inflection points, and align investment priorities with the trajectories that will define the next decade of longevity breakthroughs.

Pivotal Transformations Reshaping Anti-Aging Solutions

A profound transformation is underway as the anti-aging and longevity landscape pivots from isolated product offerings to integrated wellness ecosystems. Regulatory frameworks are adapting to accommodate novel ingredients, digital diagnostics, and personalized therapeutic models, enabling more seamless market entry for science-backed innovations. Concurrently, consumer mindsets have evolved from reactive treatments to proactive healthspan optimization, fueling demand for preventive supplements, diagnostics, and lifestyle interventions.

Technological advancements in omics platforms and biomarker analytics are providing unprecedented insights into individual aging trajectories. This shift is catalyzing the rise of precision nutraceuticals and targeted botanical extracts, offering tailored solutions that extend beyond generic formulations. Meanwhile, e-commerce proliferation and telehealth integration are democratizing access to longevity expertise, creating frictionless channels for both established brands and emerging disruptors.

Strategic alliances between biotech firms, academic institutions, and wellness providers are reshaping R&D pathways, accelerating time to market for novel compounds and delivery systems. These collaborative models are fostering agility in clinical validation and scaling of breakthrough therapies. As a result, the anti-aging market is no longer siloed but a convergent ecosystem where cross-sector partnerships drive exponential value creation and sustained consumer engagement.

Tariff Realignments Recasting Market Dynamics in 2025

The onset of new tariffs in 2025 has introduced a recalibrated cost structure across critical supply chains, prompting manufacturers and distributors to reassess sourcing strategies. Raw materials, particularly imported botanical extracts and key nutraceutical compounds, have experienced upward pressure in landed costs, compelling suppliers to negotiate volume commitments and explore alternative origins. This tariff regime has also incentivized local cultivation initiatives, with producers investing in domestic farming and extraction facilities to mitigate exposure to fluctuating duties.

Simultaneously, the recalibration of import levies has catalyzed a geographic realignment of manufacturing footprints. Several leading ingredient specialists are expanding production in North America to bypass tariffs, while others are leveraging nearshore partnerships in Mexico and Canada. These maneuvers aim to preserve price competitiveness without compromising quality standards. On the distribution front, channel margins are tightening as retailers and e-commerce platforms recalibrate order fulfillment economics to accommodate elevated supplier costs.

In response, businesses are intensifying product optimization efforts, reformulating blends to balance ingredient efficacy with cost efficiency. Some innovators are pivoting to higher-value, low-volume molecules, reducing bulk dependency on tariff-exposed inputs. Collectively, these dynamics underscore the strategic imperative for agility and cost rationalization in navigating the post-tariff landscape.

Deep-Dive into Market Segmentation Revealing Consumer Behaviors

Diving into the market’s underlying architecture reveals nuanced consumer preferences and delivery mechanisms that drive category performance. Based on product type, botanical extracts such as aloe vera and gotu kola continue to command attention for their adaptogenic and regenerative properties. Dietary supplements comprising amino acids, minerals, probiotics, and vitamins have experienced consistent uptake as foundational elements of daily wellness. Within herbal medicine, tradition-rich ingredients like ginseng, green tea, resveratrol, and turmeric maintain robust demand for their antioxidant and anti-inflammatory benefits. Nutraceutical innovations, notably coenzyme Q10, collagen, and omega-3, are carving out premium segments focused on cellular energy and structural support.

Examining distribution channels, direct sales models leverage personalized consultations to foster consumer loyalty, while hospital clinics integrate anti-aging protocols into preventative healthcare pathways. Online retail platforms have democratized access to specialized formulations, providing transparent ingredient sourcing and community-driven feedback loops. Pharmacies blend traditional trust with modern supplement curation, and specialty stores curate experiential environments that facilitate product discovery and education.

Surveying end users uncovers distinct engagement patterns among patrons of fitness centers, healthcare providers, individual consumers, and wellness centers. Each cohort exhibits unique purchase drivers, from performance optimization in athletic settings to therapeutic recommendations within clinical environments. Considering therapy types, energy therapy modalities emphasize cellular performance, manual therapy approaches address musculoskeletal integrity, and mind-body therapies optimize stress resilience. Nutritional therapy, through caloric restriction, dietary counseling, and fasting protocols, underscores metabolic recalibration, while traditional alternative systems offer culturally grounded frameworks for holistic balance.

Demographic lenses further refine the picture. Consumers aged 18 to 35 prioritize preventative regimes and digital engagement, those between 36 and 50 seek targeted intervention for early signs of aging, and individuals 51 and above invest in restorative and maintenance strategies. Gender distinctions also surface, with female consumers gravitating toward beauty-oriented formulations and male consumers emphasizing performance and vitality support. Together, these segmentation insights illuminate pathways to tailor propositions and maximize resonance across audience segments.

Regional Nuances Driving Growth Across Continents

Regional dynamics are shaping growth trajectories and competitive contours across the globe’s major blocks. In the Americas, the convergence of advanced regulatory acceptance, consumer purchasing power, and infrastructure investment continues to underpin market expansion. North American markets lead adoption of precision supplements and digital longevity platforms, while Latin American markets are rapidly embracing traditional botanical therapies in urban wellness centers.

Across Europe, Middle East & Africa, regulatory harmonization initiatives and clinical validation requirements are elevating quality benchmarks for ingredients and finished goods. Western European consumers are particularly receptive to certified organic formulations and clean-label narratives, whereas emerging markets in the Middle East and North Africa are witnessing a surge in interest around integrated spa and anti-aging clinic services. Sub-Saharan Africa presents nascent opportunities amid rising health awareness, though market penetration remains tempered by affordability considerations.

In Asia-Pacific, a rich heritage of traditional medicine converges with cutting-edge biotech research. East Asian markets, led by China, Japan, and South Korea, are at the forefront of neuroprotective and cellular reprogramming supplements. Southeast Asia is experiencing accelerated uptake of functional foods and nutraceutical beverages, capitalizing on strong consumer affinity for herbal infusions. Australia and New Zealand sustain robust demand for marine-derived omega-3 and collagen formulations, supported by stringent regulatory oversight and high per capita health expenditure. This regional tapestry underscores the necessity for adaptable go-to-market strategies and culturally attuned product positioning.

Competitive Landscape Spotlight on Leading Innovators

The competitive landscape is anchored by conglomerates and specialized pioneers deploying differentiated approaches to capture market share. Leading nutrition giants have bolstered their portfolios through strategic acquisitions of boutique herbal specialists and digital wellness startups, integrating omni-channel distribution with proprietary ingredient platforms. Simultaneously, pure-play botanicals firms are scaling global operations via co-development partnerships and licensing arrangements, ensuring wider geographic reach for their signature extracts.

Emerging biotech innovators are challenging traditional paradigms by advancing novel delivery systems such as lipid nanocarriers and peptide conjugates, enabling superior bioavailability and targeted tissue uptake. These technological differentiators are drawing venture capital and forging alliances with legacy manufacturers seeking pipeline revitalization. Collaborative research agreements between pharmaceutical entities and nutraceutical producers are also proliferating, aimed at clinical validation of combined modality regimens.

On the service front, wellness centers and precision health clinics are establishing proprietary diagnostic protocols-ranging from metabolomic profiling to epigenetic age assays-to drive recurring subscription models and personalized intervention plans. Digital health platforms harness machine learning to refine consumer insights and optimize retention. In tandem, specialty retailers curate immersive brand experiences, blending education with interactive sampling to foster consumer advocacy. Collectively, these strategic maneuvers are intensifying competitive intensity while expanding the total addressable market.

Strategic Imperatives for Industry Front-Runners

Industry leaders must prioritize the convergence of personalization and scalability by integrating advanced analytics into R&D pipelines. Allocating resources toward real‐world evidence generation will accelerate regulatory approvals and strengthen brand credibility. Cultivating strategic alliances with academic centers and contract research organizations can de‐risk innovation pathways and unlock co‐development synergies.

Optimizing supply chains through diversified sourcing and near‐shore manufacturing will mitigate tariff volatility and ensure resilience against geopolitical disruptions. Concurrently, investing in sustainable cultivation practices and transparent traceability systems will bolster consumer trust and support premium pricing strategies. On the go-to-market front, tailoring channel strategies to demographic nuances-whether engaging digital natives through influencer partnerships or leveraging clinical endorsements for mature cohorts-will enhance conversion rates and lifetime customer value.

Moreover, embedding cross-sector collaborations between biotech, digital health, and traditional wellness services can create integrated longevity offerings that deepen consumer engagement. Leaders should also intensify thought leadership through peer-reviewed research publications and high-visibility conferences to solidify their authority in the anti-aging arena. By executing these actionable imperatives, organizations can secure differentiated positioning and sustained growth in a rapidly evolving market.

Rigorous Framework Underpinning Research Integrity

This analysis synthesizes a robust blend of primary and secondary research methodologies to ensure rigorous validity and relevance. Primary insights were garnered through structured interviews with senior executives, formulation scientists, and clinical practitioners across multiple regions. These firsthand perspectives were complemented by surveys targeting consumer segments to elucidate purchasing behaviors and therapy preferences.

Secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory databases, and proprietary trade publications to map ingredient innovation pipelines and policy developments. Market intelligence was triangulated with customs data and corporate filings to quantify supply chain flows and competitive activity. Advanced analytical frameworks, including SWOT and Porter’s Five Forces, provided strategic context for competitive positioning and market attractiveness.

Data integrity was upheld through systematic cross-verification and periodic updates to reflect the latest tariff schedules and regional guidelines. Qualitative findings were validated via expert panel workshops, ensuring consensus on emerging trends and opportunity horizons. This multi-dimensional approach underpins the insights presented herein, delivering actionable intelligence grounded in empirical evidence.

Synthesizing Insights to Chart the Path Forward

The convergence of botanical heritage, nutraceutical innovation, and digital health is forging a new era in anti-aging and longevity. Market dynamics are being reshaped by regulatory evolution, shifting consumer paradigms, and strategic collaborations that transcend traditional industry boundaries. Navigating the complexities of tariffs, segmentation nuances, and regional idiosyncrasies requires a holistic perspective informed by reliable data and forward-looking analysis.

As decision-makers align their portfolios with the accelerating demand for personalized, evidence-based longevity solutions, the insights detailed in this summary provide a strategic compass. Embracing adaptive supply chain strategies, targeted product differentiation, and cross-sector partnerships will be critical to capitalizing on emerging inflection points. Ultimately, the organizations that combine scientific rigor with market agility will lead the charge in extending healthspan and enhancing quality of life across demographics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Botanical Extract
      • Aloe Vera
      • Gotu Kola
    • Dietary Supplement
      • Amino Acids
      • Minerals
      • Probiotics
      • Vitamins
    • Herbal Medicine
      • Ginseng
      • Green Tea
      • Resveratrol
      • Turmeric
    • Nutraceutical
      • Coenzyme Q10
      • Collagen
      • Omega-3
  • Distribution Channel
    • Direct Sales
    • Hospital Clinics
    • Online Retail
    • Pharmacy
    • Specialty Store
  • End User
    • Fitness Center
    • Healthcare Provider
    • Individual Consumer
    • Wellness Center
  • Therapy Type
    • Energy Therapy
    • Manual Therapy
    • Mind Body Therapy
    • Nutritional Therapy
      • Caloric Restriction
      • Dietary Counseling
      • Fasting
    • Traditional Alternative System
  • Age Group
    • 18 To 35 Years
    • 36 To 50 Years
    • 51 Years And Above
  • Gender
    • Female
    • Male
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • The Bountiful Company, LLC
  • GNC Holdings, LLC
  • Pharmavite LLC
  • USANA Health Sciences, Inc.
  • Glanbia Plc
  • H&H International Holdings Ltd
  • Nature’s Sunshine Products, Inc.
  • Jamieson Wellness Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Product Type
8.1. Introduction
8.2. Botanical Extract
8.2.1. Aloe Vera
8.2.2. Gotu Kola
8.3. Dietary Supplement
8.3.1. Amino Acids
8.3.2. Minerals
8.3.3. Probiotics
8.3.4. Vitamins
8.4. Herbal Medicine
8.4.1. Ginseng
8.4.2. Green Tea
8.4.3. Resveratrol
8.4.4. Turmeric
8.5. Nutraceutical
8.5.1. Coenzyme Q10
8.5.2. Collagen
8.5.3. Omega-3
9. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Distribution Channel
9.1. Introduction
9.2. Direct Sales
9.3. Hospital Clinics
9.4. Online Retail
9.5. Pharmacy
9.6. Specialty Store
10. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by End User
10.1. Introduction
10.2. Fitness Center
10.3. Healthcare Provider
10.4. Individual Consumer
10.5. Wellness Center
11. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Therapy Type
11.1. Introduction
11.2. Energy Therapy
11.3. Manual Therapy
11.4. Mind Body Therapy
11.5. Nutritional Therapy
11.5.1. Caloric Restriction
11.5.2. Dietary Counseling
11.5.3. Fasting
11.6. Traditional Alternative System
12. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Age Group
12.1. Introduction
12.2. 18 to 35 Years
12.3. 36 to 50 Years
12.4. 51 Years and Above
13. Complementary & Alternative Medicine For Anti Aging & Longevity Market, by Gender
13.1. Introduction
13.2. Female
13.3. Male
14. Americas Complementary & Alternative Medicine For Anti Aging & Longevity Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Complementary & Alternative Medicine For Anti Aging & Longevity Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Complementary & Alternative Medicine For Anti Aging & Longevity Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Herbalife Nutrition Ltd.
17.3.2. Amway Corp.
17.3.3. The Bountiful Company, LLC
17.3.4. GNC Holdings, LLC
17.3.5. Pharmavite LLC
17.3.6. USANA Health Sciences, Inc.
17.3.7. Glanbia Plc
17.3.8. H&H International Holdings Ltd
17.3.9. Nature’s Sunshine Products, Inc.
17.3.10. Jamieson Wellness Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET MULTI-CURRENCY
FIGURE 2. COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET MULTI-LANGUAGE
FIGURE 3. COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY ALOE VERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GOTU KOLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GINSENG, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GREEN TEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY RESVERATROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY TURMERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COENZYME Q10, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY OMEGA-3, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HOSPITAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY SPECIALTY STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY FITNESS CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HEALTHCARE PROVIDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY INDIVIDUAL CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY WELLNESS CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY ENERGY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY MIND BODY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY CALORIC RESTRICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY FASTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY TRADITIONAL ALTERNATIVE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY 18 TO 35 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY 36 TO 50 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY 51 YEARS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 82. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 83. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 84. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 85. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 89. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. CANADA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 93. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 94. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 100. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. MEXICO COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 149. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. GERMANY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 158. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 160. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 161. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 163. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 167. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. FRANCE COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 180. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 182. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 183. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 184. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 185. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 189. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. ITALY COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 191. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 193. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 194. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 195. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 196. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 200. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. SPAIN COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRITIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY BOTANICAL EXTRACT, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DIETARY SUPPLEMENT, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY HERBAL MEDICINE, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA COMPLEMENTARY & ALTERNATIVE MEDICINE FOR ANTI AGING & LONGEVITY MARKET SIZE, BY

Companies Mentioned

The companies profiled in this Complementary & Alternative Medicine For Anti Aging & Longevity market report include:
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • The Bountiful Company, LLC
  • GNC Holdings, LLC
  • Pharmavite LLC
  • USANA Health Sciences, Inc.
  • Glanbia Plc
  • H&H International Holdings Ltd
  • Nature’s Sunshine Products, Inc.
  • Jamieson Wellness Inc.

Methodology

Loading
LOADING...

Table Information